| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047447911 |
| P356 | DOI | 10.1038/NPP.2008.141 |
| P932 | PMC publication ID | 2639632 |
| P698 | PubMed publication ID | 18800069 |
| P5875 | ResearchGate publication ID | 23263584 |
| P2093 | author name string | Christian Grillon | |
| Daniel S Pine | |||
| Chanen Chavis | |||
| Matthew F Covington | |||
| P2860 | cites work | Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. | Q48526133 |
| The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. | Q48572952 | ||
| Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. | Q48579580 | ||
| A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. | Q50925503 | ||
| The SSRI antidepressants: exploring their "other" possible properties. | Q52902876 | ||
| Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression | Q70642383 | ||
| Increased anxiety of mice lacking the serotonin1A receptor | Q24655613 | ||
| Models and mechanisms of anxiety: evidence from startle studies | Q30488271 | ||
| Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders | Q33752501 | ||
| Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. | Q34264829 | ||
| Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology | Q34465555 | ||
| The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic | Q35071487 | ||
| Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. | Q37159913 | ||
| Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer | Q37182877 | ||
| Anxious responses to predictable and unpredictable aversive events. | Q40472919 | ||
| An open trial of fluoxetine in the treatment of panic attacks | Q41311345 | ||
| Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone | Q41346194 | ||
| Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm | Q42037314 | ||
| Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice | Q44014662 | ||
| Acute SSRI administration affects the processing of social cues in healthy volunteers. | Q44259244 | ||
| Tryptophan depletion decreases the recognition of fear in female volunteers | Q44391540 | ||
| Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress | Q44868502 | ||
| Anxiety sensitivity and modulation of the serotonergic system in patients with PD. | Q44882728 | ||
| The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine | Q44926896 | ||
| Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans | Q44953206 | ||
| Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition | Q44960127 | ||
| Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus | Q45079653 | ||
| Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults | Q45080045 | ||
| Antidepressant drug treatment modifies the neural processing of nonconscious threat cues | Q46929906 | ||
| Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. | Q48487138 | ||
| The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. | Q48489427 | ||
| Dorsal hippocampal contributions to unimodal contextual conditioning. | Q48496636 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 964-971 | |
| P577 | publication date | 2008-09-17 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study | |
| P478 | volume | 34 |
| Q92536147 | A Proof-of-Mechanism Study to Test Effects of the NMDA Receptor Antagonist Lanicemine on Behavioral Sensitization in Individuals With Symptoms of PTSD |
| Q47819021 | A single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women |
| Q30475110 | Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study |
| Q30453024 | Acute tryptophan depletion increases translational indices of anxiety but not fear: serotonergic modulation of the bed nucleus of the stria terminalis? |
| Q36245072 | Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test) |
| Q35007673 | Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice |
| Q39425210 | Chronic fluoxetine dissociates contextual from auditory fear memory |
| Q47925585 | Conditioned Subjective Responses to Socially Relevant Stimuli in Social Anxiety Disorder and Subclinical Social Anxiety |
| Q36822753 | Differential effects of acute and repeated citalopram in mouse models of anxiety and depression |
| Q89833674 | Distinct responses to predictable and unpredictable threat in anxiety pathologies: effect of panic attack |
| Q51821879 | Early-onset alcohol dependence increases the acoustic startle reflex. |
| Q39797567 | Effect of fluoxetine on blood concentrations of serotonin, cortisol and dehydroepiandrosterone in canine aggression |
| Q39588444 | Effects of anxiolytic treatment on potentiated startle during aversive image anticipation |
| Q88325738 | Exercise decreases defensive responses to unpredictable, but not predictable, threat |
| Q37983522 | Fear, anxiety, and control in the zebrafish. |
| Q30424359 | How bad could it be? Alcohol dampens stress responses to threat of uncertain intensity |
| Q91609151 | Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects |
| Q92940436 | Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences |
| Q38852116 | On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development |
| Q30472655 | Oxytocin reduces background anxiety in a fear-potentiated startle paradigm |
| Q30466236 | Phasic and sustained fear are pharmacologically dissociable in rats |
| Q30477934 | Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety |
| Q39302789 | Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence. |
| Q46238981 | Reactivity to unpredictable threat as a treatment target for fear-based anxiety disorders |
| Q30478689 | Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses |
| Q30446862 | Serotonergic modulation of conditioned fear |
| Q26752591 | Serotonin, Amygdala and Fear: Assembling the Puzzle |
| Q88733638 | Startling Differences: Using the Acoustic Startle Response to Study Sex Differences and Neurosteroids in Affective Disorders |
| Q30387331 | The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle |
| Q45065961 | The Unpredictive Brain Under Threat: A Neurocomputational Account of Anxious Hypervigilance. |
| Q35782856 | The adaptive threat bias in anxiety: amygdala-dorsomedial prefrontal cortex coupling and aversive amplification |
| Q48008305 | Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals |
| Q30403053 | Using the threat probability task to assess anxiety and fear during uncertain and certain threat |
Search more.